ProfileGDS4177 / 1563744_a_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 54% 48% 44% 44% 45% 48% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated39.9554
GSM603099KU-812 non-treated30.6348
GSM603098KCL-22 Imatinib-treated24.4844
GSM603097KCL-22 non-treated25.1144
GSM603102JURL-MK1 Imatinib-treated27.545
GSM603101JURL-MK1 non-treated30.5648